Journals / Retina-Vitreus / 2016 / Cilt: 24 - Sayı: 4

Management of Sub Macular Hemorrhage with Intravitreal Injection of Tissue Plasminogen Activator and Sulfur Hexafluoride

Pages
297–300
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Most patients enjoy visual improvement coincident with blood displacement.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the clinical outcome in terms of anatomical displacement of sub macular hemorrhage(SMH) and visual outcomes of intravitreal tissue plasminogen activator (tPA) and expansile gas Sulfur hexafluoride(SF6) injection as a minimally invasive treatment for SMH of duration one week or less.
📊
Key Findings & Data:Materials and Methods: This study was a retrospective clinical case series examining 44 eyes that received an intravitreal injection of 100 mcg of tPA and SF6 for SMH.
💡
Conclusion & Impact:Most patients enjoy visual improvement coincident with blood displacement.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To evaluate the clinical outcome in terms of anatomical displacement of sub macular hemorrhage(SMH) and visual outcomes of intravitreal tissue plasminogen activator (tPA) and expansile gas Sulfur hexafluoride(SF6) injection as a minimally invasive treatment for SMH of duration one week or less. Design: Retrospective non-comparative interventional case series. Materials and Methods: This study was a retrospective clinical case series examining 44 eyes that received an intravitreal injection of 100 mcg of tPA and SF6 for SMH. The main outcomes evaluated were visual acuities (VA), anatomic displacement of sub macular blood, and complications. Results: Age related macular degeneration was the etiological diagnosis in 38.5% eyes followed by trauma in 27%.Comparison of SMH size on pretreatment versus on first week follow up revealed reduction of size in majority from 2 disc diameters pretreatment in 38.6% eyes to 1 disc diameter post-treatment in 59.1% eyes. However the shifting of the SMH was observed in all cases. This was seen translating into visual gain with 31.8% eyes gaining 1-2 Snellen lines, 18.2 % gaining 2-3 lines and 13.5 % gaining 3-5 lines. Major complication was noted in 2 cases (Rebleed and break-through vitreous hemorrhage in one each). Conclusion: Intravitreous injection of tPA and gas, followed by a brief period of prone positioning, is effective in displacing thick blood from beneath the centre of the macula. The procedure is technically simple, and the rate of serious complications appears to be low. Most patients enjoy visual improvement coincident with blood displacement.

🔖

Cite This Article

DHAWAN, B., VIG, V., SINGH, P., SINGH, R. (2016). Management of Sub Macular Hemorrhage with Intravitreal Injection of Tissue Plasminogen Activator and Sulfur Hexafluoride. Retina-Vitreus, Cilt: 24 - Sayı: 4, 297–300. https://ajindex.com/articles/306855

References (13)

  1. Richards, A.J., Scott, J.D. & Snead, M.P. Molecular genetics of rhegma- togenous retinal detachment. Eye 2002;16:388-92.
  2. Schwartz, S.G., Kuhl, D.P., McPherson, A.R., Holz, E.R. & Mieler, W.F. Twenty-year follow-up for scleral buckling. Archives of ophthal- mology 2002;120:325-9.
  3. Haritoglou, C., Brandlhuber, U., Kampik, A. & Priglinger, S.G. Anato- mic success of scleral buckling for rhegmatogenous retinal detachment- -a retrospective study of 524 cases. Ophthalmologica. Journal inter- national d'ophtalmologie. international journal of ophthalmology. Zeitschrift fur Augenheilkunde 2010;224:312-8.
  4. Thompson, J.T. & Michels, R.G. Volume displacement of scleral buck- les. Archives of ophthalmology 1985;103:1822-4.
  5. Banaee, T., Hosseini, S.M., Ghooshkhanei, H., Moosavi, M. & Khay- yatzadeh-Kakhki, S. Anatomical and visual outcomes of three different scleral buckling techniques. Journal of ophthalmic & vision research 2009;4:90-6.
  6. Rezaei KA, Abrams GW. The History of retinal detachment surgery. Primary retinal detachment. Europian medical alliance 2015:1-24.
  7. Baino, F. Scleral buckling biomaterials and implants for retinal detach- ment surgery. Medical engineering & physics 2010:32:945-56.
  8. Tornambe, P.E. Pneumatic retinopexy: the evolution of case selection and surgical technique. A twelve-year study of 302 eyes. Transactions of the American Ophthalmological Society 1997;95:551-78.
  9. Tornambe, P.E. & Hilton, G.F. Pneumatic retinopexy. A multicenter randomized controlled clinical trial comparing pneumatic retinopexy with scleral buckling. The Retinal Detachment Study Group. Ophthal- mology 1989;96:772-783; discussion 784. Zaidi, A.A., Alvarado, R. & Irvine, A. Pneumatic retinopexy: success rate and complications. The British journal of ophthalmology 2006;90: 427-28.
  10. Oshima, Y., et al. Two-year follow-up study comparing primary vit- rectomy with scleral buckling for macula-off rhegmatogenous retinal detachment. Japanese journal of ophthalmology 2000;44:538-49.
  11. Liu, F., Meyer, C.H., Mennel, S., Hoerle, S. & Kroll, P. Visual recovery after scleral buckling surgery in macula-off rhegmatogenous retinal detachment. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 2006;220:174-80.
  12. Patterson, D.F. & Ryan, E.H. Controlled drainage of subretinal fluid using continuous monitoring with indirect ophthalmoscopy. JAMA ophthalmology 2013;131:228-31.
  13. Cheng, H.C., et al. Short-term external buckling with pneu